Skip to main content

Advertisement

SpringerLink
Log in

Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

In a 2-year study, we examined bone mass and calcium metabolism in 36 elderly women with moderate osteoporosis. The study period comprised 1 year of observation, during which the women received no treatment affecting calcium metabolism, and 1 year of treatment, during which all participants received daily salmon calcitonin (sCT) 100 IU rectally and calcium 500 mg. During the observational period a significant bone loss of 1.5% was seen in the forearm (P<0.01), whereas the spinal bone mass was virtually unchanged. After institution of treatment, the bone loss was arrested in the forearm and a significant increase of about 2% was seen in the spine (P<0.01). The net effect of treatment revealed a positive outcome in both bone compartments (1.9% and 2.9%, P<0.05−0.01). Correspondingly, the parameters of bone turnover (serum alkaline phosphatase, plasma bone Gla protein, and fasting urinary hydroxyproline/creatinine) did not change during the observational period, but significantly declined, 10–30%, during sCT treatment (P<0.01−0.001). Tolerance was generally good, although in one woman, anoscopy revealed irritative changes in the rectal mucosa. We conclude that, given rectally, sCT is well absorbed and well tolerated and that it has a beneficial effect on calcium metabolism in moderately osteoporotic women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Woodhouse NJY, Bordier Ph, Fisher M, Joplin GF, Reiner M, Kalu DN, Foster GV, MacIntyre I (1971) Human calcitonin in the treatment of Paget's bone disease. Lancet 1:1139–1143

    Google Scholar 

  2. Kanis JA, Horn DB, Scott RDM, Strong JA (1974) Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J 3:727–731

    Google Scholar 

  3. Milhaud G, Job J-C (1966) Thyrocalcitonin: effect on idiopathic hypercalcemia. Science 154:794–796

    Google Scholar 

  4. Hosking DJ (1980) Treatment of severe hypercalcemia with calcitonin. Metab Bone Dis Rel Res 2:207–212

    Google Scholar 

  5. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82:1268–1274

    Google Scholar 

  6. Overgaard K, Hansen MA, Nielsen V-AH, Riis BJ, Christiansen C (1990) Discontinuous calcitonin treatment of established osteoporosis-effects of withdrawal of treatment. Am J Med 89:1–6

    Google Scholar 

  7. Gennari C, Francini G, Chierichetti SM, Nami R, Gonnelli S, Piolini M (1989) Salmon calcitonin treatment in bone metastases. Curr Ther Res 45:804–812

    Google Scholar 

  8. Gennari C, Agnusdei D, Camporeale A (1991) Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int 49(S2):S9-S13

    Google Scholar 

  9. Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut CH III (1985) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295–303

    Google Scholar 

  10. Reginster JY, Franchimont P (1985) Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin Exp Rheumatol 3:155–157

    Google Scholar 

  11. Buchlin T, Randin JP, Jacqůed AF, Azria M, Addinger M, Gomez F, Bůrckhardt P (1987) The effect of rectal and nasal administration of salmon calcitonin in normal subjects. Calcif Tissue Int 41:252–258

    Google Scholar 

  12. Overgaard K, Riis BJ, Christiansen C, Pødenphant J, Johansen JS (1989) Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 30:435–442

    Google Scholar 

  13. Overgaard K, Christiansen C (1991) Long-term treatment of established osteoporosis with intranasal calcitonin. Calcif Tissue Int 48(S2):S60-S63

    Google Scholar 

  14. Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA, Lambelin P, Franchimont P (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481–1483

    Google Scholar 

  15. Overgaard K, Riis BJ, Christiansen C, Hansen MA (1989) Effects of calcitonin given intranasally on early postmenopausal bone loss. Br Med J 299:477–479

    Google Scholar 

  16. Overgaard K, Hansen MA, Riis BJ, Christiansen C (1992) Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women. Calcif Tissue Int 50:30–35

    Google Scholar 

  17. Nilas L, Borg J, Gotfredsen A, Christiansen C (1985) Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss. J Nucl Med 26:1257–1262

    Google Scholar 

  18. Hansen MA, Hassager C, Overgaard K, Riis BJ, Marslew U, Christiansen C (1990) Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine. J Nucl Med 31:1156–1162

    Google Scholar 

  19. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (1974) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 33:291–306

    Google Scholar 

  20. Johansen JS, Mølholm Hansen JE, Christiansen C (1987) A radioimmunoassay for bone Gla protein (BGP) in human plasma. Acta Endocrinol 114:410–416

    Google Scholar 

  21. Pødenphant J, Larsen N-E, Christiansen C (1984) An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 142:145–148

    Google Scholar 

  22. Christiansen C, Naestoft J, Hvidberg EF, Larsen N-E, Petersen B (1975) An easy procedure for in vivo estimation of protein binding and correction of elevated serum values induced by venous stasis. Clin Chim Acta 62:65–71

    Google Scholar 

  23. Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. Br Med J 300:230–235

    Google Scholar 

  24. Nilas L, Gotfredsen A, Hadberg A, Christiansen C (1988) Agerelated bone loss in women evaluated by the single and dual photon technique. Bone Miner 4:95–103

    Google Scholar 

  25. Riggs BL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, Cedel SL, Melton LJ III (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802–809

    Google Scholar 

  26. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Ligata AA, Ross P, Woodson GC III, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut CH III (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73–79

    Google Scholar 

  27. Overgaard K, Hansen MA, Jensen SB, Christiansen C (in press) Effect of intranasal salmon calcitonin on bone mass and fracture rates in elderly postmenopausal women. A dose-response study. Br Med J July

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Chemistry, Glostrup Hospital, University of Copenhagen, DK-2600, Glostrup, Denmark

    Kirsten Overgaard, Marc Allan Hansen, Karen-Lisbeth Dirksen & Claus Christiansen

Authors
  1. Kirsten Overgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Allan Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen-Lisbeth Dirksen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claus Christiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Overgaard, K., Hansen, M.A., Dirksen, KL. et al. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis. Calcif Tissue Int 51, 184–188 (1992). https://doi.org/10.1007/BF00334545

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00334545

Key words

Search

Navigation